Bluebird bio Inc

NASDAQ:BLUE   4:00:00 PM EDT
8.49
+0.88 (+11.56%)
7:59:55 PM EDT: $8.47 -0.02 (-0.24%)
Earnings Announcements

Bluebird Bio Reports Third Quarter 2022 Financial Results

Published: 11/07/2022 12:08 GMT
Bluebird bio Inc (BLUE) - Bluebird Bio Reports Third Quarter 2022 Financial Results and Highlights Operational Progress.
Chris Krawtschuk Appointed Chief Financial Officer.
Revenue is expected to be $30.9 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $7.75 Million
Next Quarter EPS Guidance is expected to be -$0.50

More details on our Analysts Page.